With a critical World Health Assembly vote just weeks away (May 18–23), a controversial WHO proposal—the Pathogen Access and Benefit Sharing (PABS) System—is raising urgent global concerns about biosecurity, government power, and pandemic risk.

Reggie Littlejohn (J.D., M.Div.), founder of Anti-Globalist International and a leading voice on sovereignty and human rights, is available for interview ahead of a timely expert briefing happening today (April 22).

Littlejohn warns the PABS framework could centralize control of the world’s most dangerous pathogens under unelected global authorities, increasing risks of lab leaks, biosecurity failures, and potential misuse—while lacking clear restrictions on gain-of-function research. An “Urgent Legal Notice” from the Global Health Responsibility Agency has already deemed the current design “institutionally and legally indefensible.”

Talking Points:

What the WHO’s PABS system actually does—and why the upcoming vote matters

Risks of global pathogen sharing and lab safety concerns

Implications for national sovereignty and civil liberties

The role of pharmaceutical interests in shaping pandemic policy